Cortes IMpassion132 FON IFG - Future Medicine...E˜cacy of atezolizumab plus chemotherapy versus...

Preview:

Citation preview

  • Title of articleIMpassion132 Phase III trial: atezolizumab and chemotherapy in early relapsing metastatic triple-negative breast cancer

    Article details

    AuthorsJavier Cortés, Fabrice André, Anthony Gonçalves, Sherko Kümmel, Miguel Martín, Peter Schmid, Florian Schuetz, Sandra M Swain, Valerie Easton, Erika Pollex, Regula Deurloo & Rebecca Dent

    Article URLwww.futuremedicine.com/doi/10.2217/fon-2019-0059

    Trial registration numberNCT03371017

    Primary objectives/rationale

    Key eligibility criteria

    Primary objectiveE�cacy of atezolizumab plus chemotherapy versus placebo plus chemotherapy in patients with early-relapsing (

Recommended